Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

VAQAR AHMAD

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1225062359
CMS profile
146368
Location
MIDWEST CITY, OK

General Payments · PY2018–2024

$49,354.96

  • Reported across 181 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$559.75

29 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $559.75 29

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Xeris Pharmaceuticals, Inc. $135.06 7
DEXCOM, INC. $96.71 5
Lilly USA, LLC $86.23 4
Novo Nordisk AS $65.38 3
Ascensia Diabetes Care US Inc. $59.86 3
Insulet Corporation $51.55 3
Exact Sciences Corporation $30.42 2
Amgen Inc. $18.55 1
ABBVIE INC. $15.99 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $23,338.98 41
PY2019 $12,149.10 21
PY2020 $7,621.30 38
PY2021 $4,915.52 19
PY2022 $527.28 23
PY2023 $243.03 10
PY2024 $559.75 29

Payment records · PY2024 (29)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $15.99 12/11/2024 Food and Beverage Undisputed 01/23/2026 1103184420 CMS
Amgen Inc. $18.55 01/09/2024 Food and Beverage Undisputed 01/23/2026 1115411897 CMS
Ascensia Diabetes Care Us Inc. $18.59 06/24/2024 Food and Beverage Undisputed 01/23/2026 1089093471 CMS
Ascensia Diabetes Care Us Inc. $18.08 08/21/2024 Food and Beverage Undisputed 01/23/2026 1089093469 CMS
Ascensia Diabetes Care Us Inc. $23.19 10/17/2024 Food and Beverage Undisputed 01/23/2026 1089093473 CMS
Dexcom, Inc. $15.00 01/25/2024 Food and Beverage Undisputed 01/23/2026 1153342457 CMS
Dexcom, Inc. $25.12 05/16/2024 Food and Beverage Undisputed 01/23/2026 1153342459 CMS
Dexcom, Inc. $20.72 08/16/2024 Food and Beverage Undisputed 01/23/2026 1153342461 CMS
Dexcom, Inc. $15.50 09/23/2024 Food and Beverage Undisputed 01/23/2026 1153342463 CMS
Dexcom, Inc. $20.37 11/12/2024 Food and Beverage Undisputed 01/23/2026 1153342465 CMS
Exact Sciences Corporation $15.69 05/21/2024 Food and Beverage Undisputed 01/23/2026 1114571127 CMS
Exact Sciences Corporation $14.73 11/11/2024 Food and Beverage Undisputed 01/23/2026 1114571131 CMS
Insulet Corporation $15.96 03/14/2024 Food and Beverage Undisputed 01/23/2026 1116806214 CMS
Insulet Corporation $18.13 04/18/2024 Food and Beverage Undisputed 01/23/2026 1116806212 CMS
Insulet Corporation $17.46 07/11/2024 Food and Beverage Undisputed 01/23/2026 1116811559 CMS
Lilly USA, LLC $17.40 04/03/2024 Food and Beverage Undisputed 01/23/2026 1135470591 CMS
Lilly USA, LLC $24.15 07/26/2024 Food and Beverage Undisputed 01/23/2026 1135488326 CMS
Lilly USA, LLC $24.15 07/29/2024 Food and Beverage Undisputed 01/23/2026 1135488328 CMS
Lilly USA, LLC $20.53 11/19/2024 Food and Beverage Undisputed 01/23/2026 1135470589 CMS
Novo Nordisk Inc $20.02 04/24/2024 Food and Beverage Undisputed 01/23/2026 1097530912 CMS
Novo Nordisk Inc $23.86 08/01/2024 Food and Beverage Undisputed 01/23/2026 1096887162 CMS
Novo Nordisk Inc $21.50 10/29/2024 Food and Beverage Undisputed 01/23/2026 1097775003 CMS
Xeris Pharmaceuticals, Inc. $23.15 01/23/2024 Food and Beverage Undisputed 01/23/2026 1144616631 CMS
Xeris Pharmaceuticals, Inc. $16.20 04/11/2024 Food and Beverage Undisputed 01/23/2026 1144616633 CMS
Xeris Pharmaceuticals, Inc. $19.66 04/17/2024 Food and Beverage Undisputed 01/23/2026 1144616637 CMS
Xeris Pharmaceuticals, Inc. $22.21 05/01/2024 Food and Beverage Undisputed 01/23/2026 1144616635 CMS
Xeris Pharmaceuticals, Inc. $15.39 06/19/2024 Food and Beverage Undisputed 01/23/2026 1144616639 CMS
Xeris Pharmaceuticals, Inc. $18.47 07/18/2024 Food and Beverage Undisputed 01/23/2026 1144616643 CMS
Xeris Pharmaceuticals, Inc. $19.98 08/22/2024 Food and Beverage Undisputed 01/23/2026 1144616641 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.